Pharmacokinetic considerations on the repurposing of ivermectin for
treatment of COVID-19
- Ricardo Pena Silva,
- Stephen Duffull,
- Andrew Steer,
- Sandra Jaramillo Rincon,
- Amanda Gwee,
- Xiao Zhu
28 Apr 2020Submitted to British Journal of Clinical Pharmacology 29 Apr 2020Submission Checks Completed
29 Apr 2020Assigned to Editor
04 May 2020Reviewer(s) Assigned
20 May 2020Review(s) Completed, Editorial Evaluation Pending
21 May 2020Editorial Decision: Revise Minor
02 Jun 20201st Revision Received
09 Jun 2020Submission Checks Completed
09 Jun 2020Assigned to Editor
09 Jun 2020Review(s) Completed, Editorial Evaluation Pending
16 Jun 2020Editorial Decision: Accept